BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18319319)

  • 1. Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men.
    Cartier A; Lemieux I; Alméras N; Tremblay A; Bergeron J; Després JP
    J Clin Endocrinol Metab; 2008 May; 93(5):1931-8. PubMed ID: 18319319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma soluble tumour necrosis factor-alpha receptor 2 is elevated in obesity: specific contribution of visceral adiposity.
    Cartier A; Côté M; Bergeron J; Alméras N; Tremblay A; Lemieux I; Després JP
    Clin Endocrinol (Oxf); 2010 Mar; 72(3):349-57. PubMed ID: 19650780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial variations of plasma inflammatory markers in abdominally obese men.
    Blackburn P; Després JP; Lamarche B; Tremblay A; Bergeron J; Lemieux I; Couillard C
    Obesity (Silver Spring); 2006 Oct; 14(10):1747-54. PubMed ID: 17062804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related differences in inflammatory markers in men: contribution of visceral adiposity.
    Cartier A; Côté M; Lemieux I; Pérusse L; Tremblay A; Bouchard C; Després JP
    Metabolism; 2009 Oct; 58(10):1452-8. PubMed ID: 19595381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of serum interleukin-6 and tumor necrosis factor alpha levels with abdominal fat distribution evaluated by ultrasonography in overweight or obese postmenopausal women.
    Fenkci S; Rota S; Sabir N; Sermez Y; Guclu A; Akdag B
    J Investig Med; 2006 Dec; 54(8):455-60. PubMed ID: 17169269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea.
    Vgontzas AN; Trakada G; Bixler EO; Lin HM; Pejovic S; Zoumakis E; Chrousos GP; Legro RS
    Metabolism; 2006 Aug; 55(8):1076-82. PubMed ID: 16839844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6.
    Park HS; Park JY; Yu R
    Diabetes Res Clin Pract; 2005 Jul; 69(1):29-35. PubMed ID: 15955385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging determined visceral fat reduction associates with enhanced IL-10 plasma levels in calorie restricted obese subjects.
    Formoso G; Taraborrelli M; Guagnano MT; D'Adamo M; Di Pietro N; Tartaro A; Consoli A
    PLoS One; 2012; 7(12):e52774. PubMed ID: 23300769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.
    Ruge T; Lockton JA; Renstrom F; Lystig T; Sukonina V; Svensson MK; Eriksson JW
    Metabolism; 2009 Jun; 58(6):860-6. PubMed ID: 19375766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androstane-3alpha,17beta-diol glucuronide as a steroid correlate of visceral obesity in men.
    Tchernof A; Labrie F; Bélanger A; Prud'homme D; Bouchard C; Tremblay A; Nadeau A; Després JP
    J Clin Endocrinol Metab; 1997 May; 82(5):1528-34. PubMed ID: 9141545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?
    Brochu M; Tchernof A; Dionne IJ; Sites CK; Eltabbakh GH; Sims EA; Poehlman ET
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1020-5. PubMed ID: 11238480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system.
    Straczkowski M; Dzienis-Straczkowska S; Stêpieñ A; Kowalska I; Szelachowska M; Kinalska I
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4602-6. PubMed ID: 12364441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of glucose tolerance and plasma insulin levels to the relationships between body fat distribution and plasma lipoprotein levels in women.
    Ferland M; Després JP; Nadeau A; Moorjani S; Tremblay A; Lupien PJ; Thériault G; Bouchard C
    Int J Obes; 1991 Oct; 15(10):677-88. PubMed ID: 1752729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men.
    Côté M; Mauriège P; Bergeron J; Alméras N; Tremblay A; Lemieux I; Després JP
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1434-9. PubMed ID: 15598678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of insulin resistance in patients with obesity: a pilot study.
    Stepien M; Stepien A; Wlazel RN; Paradowski M; Rizzo M; Banach M; Rysz J
    Angiology; 2014 Jan; 65(1):22-30. PubMed ID: 23267236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.
    He G; Andersen O; Haugaard SB; Lihn AS; Pedersen SB; Madsbad S; Richelsen B
    Eur J Clin Invest; 2005 Sep; 35(9):583-90. PubMed ID: 16128865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus.
    Daniele G; Guardado Mendoza R; Winnier D; Fiorentino TV; Pengou Z; Cornell J; Andreozzi F; Jenkinson C; Cersosimo E; Federici M; Tripathy D; Folli F
    Acta Diabetol; 2014 Feb; 51(1):123-31. PubMed ID: 24370923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
    Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumor necrosis factor-alpha in a children population with overweight].
    Carrizo Tdel R; Díaz EI; Velarde MS; Prado MM; Bazán MC; Abregú AV
    Medicina (B Aires); 2013; 73(4):310-4. PubMed ID: 23924528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body fat changes and activity of tumor necrosis factor α system--a 5-year follow-up study.
    Olszanecka-Glinianowicz M; Chudek J; Kocełak P; Szromek A; Zahorska-Markiewicz B
    Metabolism; 2011 Apr; 60(4):531-6. PubMed ID: 20580040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.